Paul Murphy
Ceist:1522. Deputy Paul Murphy asked the Minister for Health if the National Gender Service is aware of EMA/147755/2020 "restrictions in use of cyproterone due to meningioma risk" and the 2021 paper "Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study"; and what initial dose they use for cyproterone acetate. [14906/24]
Amharc ar fhreagra